These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12816733

  • 1. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.
    Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D'Armiento JM, Rothman PB, Powell CA.
    Am J Respir Cell Mol Biol; 2003 Dec; 29(6):694-701. PubMed ID: 12816733
    [Abstract] [Full Text] [Related]

  • 2. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
    Feng G, Xu X, Youssef EM, Lotan R.
    Cancer Res; 2001 Nov 01; 61(21):7999-8004. PubMed ID: 11691825
    [Abstract] [Full Text] [Related]

  • 3. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY, Ladeda V, Filmus J.
    Oncogene; 2001 Nov 01; 20(50):7408-12. PubMed ID: 11704870
    [Abstract] [Full Text] [Related]

  • 4. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor.
    Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB.
    Chest; 2002 Mar 01; 121(3 Suppl):6S-7S. PubMed ID: 11893651
    [No Abstract] [Full Text] [Related]

  • 5. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.
    J Pathol; 2006 Oct 01; 210(2):192-204. PubMed ID: 16915569
    [Abstract] [Full Text] [Related]

  • 6. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1668-82. PubMed ID: 18000218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ.
    Lung Cancer; 2010 Dec 21; 70(3):253-62. PubMed ID: 20338664
    [Abstract] [Full Text] [Related]

  • 13. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
    Yuan S, Yu Z, Liu Q, Zhang M, Xiang Y, Wu N, Wu L, Hu Z, Xu B, Cai T, Ma X, Zhang Y, Liao C, Wang L, Yang P, Bai L, Li Y.
    Oncogene; 2016 Nov 24; 35(47):6120-6131. PubMed ID: 27157618
    [Abstract] [Full Text] [Related]

  • 14. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G, Fong KM, Girard L, Seidl S, End-Pfützenreuter A, Lang G, Gazdar AF, Minna JD, Zielinski CC, Zöchbauer-Müller S.
    Oncogene; 2006 Feb 09; 25(6):959-68. PubMed ID: 16205641
    [Abstract] [Full Text] [Related]

  • 15. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F.
    Oncogene; 2006 Apr 27; 25(18):2628-35. PubMed ID: 16369491
    [Abstract] [Full Text] [Related]

  • 16. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.
    Kobayashi K, Nishioka M, Kohno T, Nakamoto M, Maeshima A, Aoyagi K, Sasaki H, Takenoshita S, Sugimura H, Yokota J.
    Oncogene; 2004 Apr 15; 23(17):3089-96. PubMed ID: 14755238
    [Abstract] [Full Text] [Related]

  • 17. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
    Mao X, Seidlitz E, Ghosh K, Murakami Y, Ghosh HP.
    Cancer Res; 2003 Nov 15; 63(22):7979-85. PubMed ID: 14633730
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line.
    Ruan J, Liu F, Chen X, Zhao P, Su N, Xie G, Chen J, Zheng D, Luo R.
    Int J Mol Med; 2011 Oct 15; 28(4):497-503. PubMed ID: 21617840
    [Abstract] [Full Text] [Related]

  • 19. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 20. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H, Huber R, Schlessinger D, Morin PJ.
    Cancer Res; 1999 Feb 15; 59(4):807-10. PubMed ID: 10029067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.